Cardiovascular Disease Doctors in Huntington Beach, CA Accepting Medicare

6 Cardiovascular Disease doctors found. Showing 1 - 6

Cyril Y Leung, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7636 Park Bay Dr, Huntington Beach, CA 92648 Phone: 562-595-9799    Fax: 562-595-8884

Chingfong Chin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 17822 Beach Blvd, Ste 252, Huntington Beach, CA 92647 Phone: 714-843-5770    Fax: 714-843-5668

Cao Van Pham, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 17742 Beach Blvd, Suite #230, Huntington Beach, CA 92647 Phone: 714-848-0032    Fax: 714-847-4442

Arthur Calick, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7313 Arcadia Dr, Huntington Beach, CA 92648 Phone: 714-655-4737

Dr. Rodney Nathan Ranaei, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18652 Florida St Ste 150, Huntington Beach, CA 92648 Phone: 714-751-1150    Fax: 714-751-1650

Dr. Jesse Wasley, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 17822 Beach Blvd,, Suite 243, Huntington Beach, CA 92647 Phone: 714-843-9060    Fax: 714-843-0699

News Archive

Chiron CEO to appear before the U.S. Senate Special Committee on Aging

Chiron Corporation announced that president and chief executive officer Howard Pien will appear before the U.S. Senate Special Committee on Aging in Washington, D.C., today in a hearing titled, "Combating the Flu: Keeping Seniors Alive."

Entasis and GARDP partner to develop oral antibiotic for treatment of drug-resistant gonorrhea

Zoliflodacin, a novel first-in-class oral antibiotic and one of the only treatments in development to address the rapidly-growing threat of drug-resistant gonorrhea will enter pivotal trials, thanks to a new partnership between the not-for-profit Global Antibiotic Research and Development Partnership and Entasis Therapeutics.

Viewpoints: Baucus applauds 'listening to customers' on employer mandate delay; Unions 'wake up' to problems with health law; Medicare's 'two midnights' rule

Any successful business leader will tell you the importance of listening to customers, gathering their input and suggestions and always putting them first. That lesson was not lost on the Obama administration earlier this month when it correctly decided to push back the implementation of the Affordable Care Act's employer responsibility provision -; the employer mandate -; until 2015. I'm sure this was a tough call, but it was the right one. It shows the administration is listening to the business community and working to address its concerns, as well as the concerns of Congress (Sen. Max Baucus, D-Mont., 7/17).

BioLineRx receives two U.S. patent allowances for BL-1021 to treat neuropathic pain

BioLineRx, a biopharmaceutical development company, announced today that two Notices of Allowance have been issued by the United States Patent and Trademark Office (USPTO) for BL-1021, an orally available small molecule for treating neuropathic pain.

Scientists urge caution on common antimicrobial chemicals Triclosan and Triclocarban

There are two ingredients, triclosan and triclocarban, that are used in several cleaning products such as soaps, toothpastes, detergents, carpets, paints etc. They are mainly used to kill the microbes such as bacteria, fungi and viruses. These chemicals however persist in the environment and continue to pose a risk says a new stud

Read more Medical News

› Verified 5 days ago